Osmind
@osmind
The premier technology platform for breakthrough mental health treatment and research. Learn more at Osmind.org
Join us for Q’s with Koo, a live event hosted by Dr. Martha Koo and members of the Psychiatry Collective as we explore what’s new in interventional psychiatry, from practice tips to clinical considerations. 🗓️When: Thursday, Aug 27, 11:00 AM - 11:30 AM PDT / 2 - 2:30 PM ET
Before you add another provider, machine, or location, answer one question: Can you see where patients are falling through the cracks?
200 miles from the nearest major city, Cassandra Heuer opened her psychiatry practice, Elevate Wellness & Psychiatry in her hometown of 14,000 people.
Osmind is partnering with Tasman Therapeutics to accelerate the development and commercialization of innovative treatments for neuropsychiatric disorders.
Get dedicated COMP360 resources. Prepare your practice for psychedelics. Get Access to the resource vault by filling out a 1-minute survey (link in comments →)
If you're attending and want to connect about our collaboration with the APA, measurement-based care, real-world evidence, or what it takes to scale interventional treatments, we'd love to meet. Reach out or find us on-site.
Looking to lower your SPRAVATO® drug costs and streamline your practice operations? Join our monthly SPRAVATO® office hours hosted live inside the Psychiatry Collective on May 5th at 9 am PT / 12 pm ET.
Osmind is proud to collaborate with Compass Pathways to help independent psychiatry practices prepare for the potential future delivery of psychedelic medicine.
our patients started a GLP-1 for weight loss. Then they stopped drinking. Then they quit smoking. Then the compulsive shopping slowed down. Sound familiar? You're not alone. This is just one of the conversations happening right now inside the Psychiatry Collective.
Osmind is excited to partner with LivaNova to support education and awareness for clinicians caring for people living with difficult-to-treat depression (DTD).
This year, Osmind Scientific Advisor L. Alison McInnes MD, MS. takes the main stage to present real-world data on ketamine for PTSD from 1,340 patients across our network.
VNS therapy exists because a scientist went to Lamaze class with his pregnant wife...
Osmind is presenting our poster: "Differential Associations of Body Mass Index with Depression, Anxiety, and PTSD Symptom Trajectories in Patients Receiving Ketamine Infusion Therapy in the Real World" at the American College of Neuropsychopharmacology (ACNP) annual meeting. See you there!
Osmind leadership, including Lucia Huang, Jimmy Qian, and William Sauve, presented a webinar as part of Cantor Fitzgerald's biotechnology webinar series "Let's Do Some Psychedelics!" led by Josh Schimmer.
If you're looking to stay current without the isolation, join The Psychiatry Collective and connect with psychiatrists who are actively advancing their practices.
At Osmind, we're building tools that help psychiatrists deliver evidence-based, measurement-driven care that focuses on outcomes that matter. Conferences like this remind us why that work is so important. Thanks to everyone who made Behavioral Health Tech such a thought-provoking few days.
You never know which conversation will spark a wave of transformation in behavioral health care.
Solo practice means you're good at what you do. It also means you're isolated. Dr. Jacob Behrens, MD runs Envision ADHD in Wisconsin. He joined The Psychiatry Collective to stay current on emerging treatments—but discovered something more valuable than research updates.
"This TMS chair is not Santa's sleigh; it doesn't run on belief." For patients already carrying the weight of their illness, removing the burden of belief can be transformative. Listen to the full conversation by searching "Psychiatry Tomorrow" on your favorite podcast platform!
Mental healthcare takes a village. We need each other. We're grateful for the researchers asking hard questions, the clinicians showing up every day, and the pioneers trying new approaches when the old ones aren't enough. You're making a difference.
"The cat's out of the bag. I don't see a world in future psychiatry that's just medicine and therapy." Martha B. Koo, M.D. doesn't mince words about where psychiatry is headed.
We're honored that Osmind has been selected from thousands of companies globally as a finalist for: The Digital Health Hub Foundation - Digital Health Awards in the Best in Class track - Mental and Behavioral Health category!
Must be a Psychedelic Medicine Association (PMA) member to attend. To learn more and sign up visit: members.psychedelicmedicineassociation.org/c/webinars/i...
Dr. Albright also capped the conference off helping bring interventional psychiatry to more clinicians. Her work continues to drive the field forward! Cheers to more conversations on how we can use data, technology, and research to help people benefit from innovative mental health treatments!
What a nice surprise this week to have TIME recognize Osmind as one of the World's Top Health Tech Companies of 2025!
We're proud to announce that Osmind has been selected from thousands of companies globally as a quarterfinalist for The Digital Health Hub Foundation - Digital Health Awards in the Best in Class track - Mental and Behavioral Health category!